Clinical Study Objective
The objective of this study was to assess the PureFix Elixir on women with poor hair conditions and hair thinning over a 3-month period, using expert visual grading and self-perception questionnaires.
At the start of the clinical trial, an expert hair evaluator assessed each woman’s hair condition using a 6-point scale where 0 was very poor and 5 was great. At the start of the trial the average score for hair condition was 2.82.
After 3 months, the average hair condition score increased to 4.57. In total, after three months of using the PureFix Elixir, 96% of participants hair condition improved compared to the start of the study.
Additionally, the clinical trial assessed participants hair thinning. An expert hair evaluator assessed participants’ hair for signs of thinning at the start of the study using a 6 point scale where 0 = no evidence of thinning hair and 5 = extreme evidence of hair loss/balding.
The average hair thinning score at the start of the study was 3.36. After three months of using the PureFix Elixir, the average hair thinning score dropped to 0.75. As noted by the expert hair evaluator, 100% of women in the clinical trial improved in the signs of hair thinning for the areas addressed.
This study took place between July and October 2020.